NEW YORK, NY, July  06, 2026  (GLOBE NEWSWIRE) --  Bleichroeder Acquisition Corp. III (the &#34;Company&#34;) announced today the pricing of its initial public offering of 30,000,000 units. The units are expected to be

BCCQU

Bleichroeder Acquisition Corp. III Announces the Pricing of $300,000,000 Initial Public Offering

BCCQU IPO Priced: 30 Million Units Debut on Nasdaq

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, NY, July  06, 2026  (GLOBE NEWSWIRE) --  Bleichroeder Acquisition Corp. III (the &amp;#34;Company&amp;#34;) announced today the pricing of its initial public offering of 30,000,000 units. The units are expected to be</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>BCCQU priced its IPO at 30 million units with a Nasdaq debut set for July 7, 2026. Each unit includes one Class A share and a quarter of a warrant exercisable at $11.50; separate trading for BCCQ and BCCQW will begin after units start trading. An over-allotment option of up to 4.5 million units could add dilution, while the SPAC targets disruptive growth in North American and European markets.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Bleichroeder Acquisition III prices 30M units; Nasdaq listing July 7 under BCCQU.</li><li>Each unit includes 1 Class A share and 1/4 redeemable warrant; warrant exercisable at $11.50.</li><li>After units begin trading, shares trade as BCCQ and warrants as BCCQW.</li><li>Underwriters have a 45-day option to buy up to 4.5M additional units.</li><li>SPAC targets North American/European disruptive growth sectors; experienced management team.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Bleichroeder Acquisition Corp. III (BCCQU)</strong>: IPO details and Nasdaq debut; primary issuer behind the SPAC.</li><li><strong>Cohen &amp; Company Capital Markets</strong>: Lead book-running manager; credibility and underwriting capacity.</li><li><strong>Michel Combes</strong>: Co-Founder; key driver of strategic direction and deal origination.</li><li><strong>Andrew Gundlach</strong>: Co-Founder; board influence on structuring and targets.</li><li><strong>Marcello Padula</strong>: Chief Executive Officer; central to execution of merger plan.</li><li><strong>Robert Folino</strong>: Chief Financial Officer; financial oversight and capital structure.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. This is a SPAC IPO pricing and listing with stated management and target focus, not an earnings or regulatory action, but it sets the stage for potential merger activity that could impact the stock if a deal materializes.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>IPO pricing and Nasdaq debut may cause initial price movement for BCCQU.</li><li>45-day over-allotment could dilute existing holders if exercised.</li><li>Separation into BCCQ and BCCQW may create liquidity and spread dynamics.</li><li>Management focus on disruptive growth sectors could influence future deal pipeline.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>30,000,000 units priced; Nasdaq listing July 7, 2026; ticker BCCQU.</li><li>Warrants exercisable at $11.50 per share; 1/4 of a warrant per unit.</li><li>Separate trading of BCCQ and BCCQW expected after unit trading begins.</li><li>Underwriters may purchase up to 4,500,000 additional units (45-day option).</li><li>SPAC focus: North American/European disruptive growth sectors; management team includes Combes, Gundlach, Padula, Folino.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral near-term; value hinges on merger news within 6–12 months.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">NEW YORK, NY, July  06, 2026  (GLOBE NEWSWIRE) --  Bleichroeder Acquisition Corp. III (the "Company") announced today the pricing of its initial public offering of 30,000,000 units. The units are expected to be listed on The Nasdaq Stock Global Market ("Nasdaq") and begin trading tomorrow, July 7, 2026, under the ticker symbol "BCCQU." Each unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "BCCQ" and "BCCQW," respectively. The offering is expected to close on July 8, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.</p>  <p align="justify">The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any industry, sector or geographic region. The Company’s primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption. The Company’s management team is led by its Co-Founders, Michel Combes and Andrew Gundlach, Marcello Padula, its Chief Executive Officer, and Robert Folino, its Chief Financial Officer. The Board also includes Clemence Rasigni and Christopher Kellen.</p>  <p align="justify">Cohen &amp; Company Capital Markets is acting as Lead Book-Running Manager for the offering.</p>  <p align="justify">The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Cohen &amp; Company Capital Markets, a division of Cohen &amp; Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: <a href="https://www.globenewswire.com/Tracker?data=8YfCLFTpOCQycxe4MZgUgI4LXmDUskMdA7TAdTxyJZaL-TuWtDyBljb1n7r_vf6GQBtzhOe0OKiQrlIb5ZVGcgwWakvxHUL_-ySZzDypI8OlQWpStrTpKSAmYQ2ECVQs" rel="nofollow" target="_blank">capitalmarkets@cohencm.com</a>.</p>  <p align="justify">A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the "SEC") and became effective on July 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>  <p align="justify"><b>Forward-Looking Statements</b></p>  <p align="justify">This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all.</p>  <p align="justify">Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.</p>  <p>Company Contact:</p>  <p>Bleichroeder Acquisition Corp. III<br></br>1345 Avenue of the Americas, 47th Floor New York, NY 10105<br></br>Attn: Robert Folino<br></br>(o) 212.984.3835<br></br><a href="https://www.globenewswire.com/Tracker?data=bqYOgLpnLRD_sIM5RpNYq2nsCCQxRq2VwsQ3Lm6WegOmWs9Tcg3oqO0w3Bj5OwsVPro86n27gfTc-YJvKwA2HevcCfcu-H2LFHHZmJpQBGtnN01NRdGbZpjXBwBwjUqf" rel="nofollow" target="_blank">robert.folino@bspac1.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc1NzgxMyM3NjkzNjY0IzUwMDE2NDk1MQ=="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NTEwMDAwZWMtY2Q4My00MDhjLTgzZWMtOWFkNzI4NGJlODNhLTUwMDE2NDk1MS0yMDI2LTA3LTA2LWVu/tiny/Bleichroeder-Acquisition-Corp-.png" referrerpolicy="no-referrer-when-downgrade"></img>

BCCQU priced its IPO at 30 million units with a Nasdaq debut set for July 7, 2026. Each unit includes one Class A share and a quarter of a warrant exercisable at $11.50; separate trading for BCCQ and BCCQW will begin after units start trading. An over-allotment option of up to 4.5 million units could add dilution, while the SPAC targets disruptive growth in North American and European markets.

Bleichroeder Acquisition Corp. III Announces the Pricing of $300,000,000 Initial Public Offering

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News